Denmark· DK-28105479814
Bilaska
A bilastin product containing bilastin, registered in Denmark by Orifarm A/S. The same ATC class is registered in 11 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Bilastin is registered in 11 of 19 countries.
Countries holding a registration under ATC R06AX29 (bilastin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 7 of them publish a price we can compare per daily dose
Bilastin · ATC R06AX29
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of bilastin costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.14 in France to $0.45 in Switzerland — a ×3.3 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Bilastin · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.45
- FR France$0.14
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Bilastin
- Manufacturer
- Orifarm A/S
- Country
- Denmark (DK)
- ATC code
- R06AX29
- ATC class
- Bilastin
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105479814
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under R06AX29
Bilastin, as other registers publish it.
- CzechiaABISAXGlenmark Pharmaceuticals s.r.o., Praha
- CzechiaABISAXGlenmark Pharmaceuticals s.r.o., Praha
- CzechiaABISAXGlenmark Pharmaceuticals s.r.o., Praha
- CzechiaABISAXGlenmark Pharmaceuticals s.r.o., Praha
- CzechiaABISAXGlenmark Pharmaceuticals s.r.o., Praha
- CzechiaABISAXGlenmark Pharmaceuticals s.r.o., Praha
- CzechiaABISAXGlenmark Pharmaceuticals s.r.o., Praha
- CzechiaABISAXGlenmark Pharmaceuticals s.r.o., Praha
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/974349af-2e2a-4cc5-9a29-7760d9821318 GET /v1/drugs/974349af-2e2a-4cc5-9a29-7760d9821318?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "tabletter",
"source": "dkma",
"strength": "20 mg",
"auth_role": "DKMA",
"dk_drugid": "28105479814",
"substance": "Bilastin",
"auth_procedure": "Par-Imp",
"in_medicinpriser": true,
"registration_date_serial": "41908"
}See everything about bilastin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.